2026. Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases as Potential EGFR Inhibitors for NSCLC. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 5 (Jan. 2026), 973–991. DOI:https://doi.org/10.32947/ajps.v25i5.1318.